CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 51 enrolled
Drug / intervention
Skinstylus microneedling devicedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06032286
NCT06032286N/ACompleted

Evaluation of Efficacy and Safety of the Skinstylus Sterilock Microneedling System for the Treatment of Facial Wrinkles

Beauty Health·interventional·Posted Sep 11, 2023·Updated Aug 7, 2024

In Brief

A clinical study evaluating Skinstylus microneedling device for Subjects Displaying Facial Ageing. Completed, enrolled 51 participants across 2 sites.

Detailed Summary

To assess the efficacy and safety of the Skin stylus Sterilock microneedling system in reducing the appearance of facial wrinkles.This study is intended to be a single arm study. Suitable subjects who meet all inclusion criteria and consented will undergo 4 microneedling sessions at baseline and days 30, 60 and 90. Subjects will be assessed at days 90, 120 and finally at day 150 by a physician utilizing the wrinkle grading scale developed by Lemperle (2001) and skin laxity and texture using a modified Alexiandes Armenakas (2010) grading scale.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202420252026
First PostedSep 11, 2023
Enrollment StartSep 8, 2023
Primary CompletionMay 9, 2024
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 2.8 years ago

Interventions

Skinstylus microneedling devicedevice

Microneedling, also known as percutaneous collagen induction (PCI), is a minimally invasive technique where small needles create microscopic wounds in the skin inducing collagen formation.